Can persistent organic pollutants explain the association between serum γ-glutamyltransferase and type 2 diabetes?

被引:63
作者
Lee, D. -H. [1 ,2 ]
Steffes, M. W. [3 ]
Jacobs, D. R., Jr. [4 ,5 ]
机构
[1] Kyungpook Natl Univ, Sch Med, Dept Prevent Med, Taegu 700422, South Korea
[2] Kyungpook Natl Univ, Sch Med, Hlth Promot Res Ctr, Taegu 700422, South Korea
[3] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA
[5] Univ Oslo, Dept Nutr, Oslo, Norway
关键词
environmental pollutants; gamma-glutamyltransferase; obesity; persistent organic pollutants; type; 2; diabetes;
D O I
10.1007/s00125-007-0896-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The results of several epidemiological studies of serum gamma-glutamyltransferase (GGT) led us to hypothesise that associations of GGT within its normal range with type 2 diabetes may reflect detrimental effects of xenobiotics found in the environment, such as persistent organic pollutants (POPs). Epidemiological observations showed that serum GGT activity within its normal range strongly predicted future type 2 diabetes; the predictability of diabetes from obesity was low with GGT at the low end of the normal range; and GGT showed a positive association with known markers of oxidative stress or inflammation. Experimental findings on cellular GGT suggest that serum GGT levels within the normal range may reflect oxidative stress related to the re-synthesis of intracellular glutathione; however, this interpretation is not completely satisfying because, in its role of regenerating intracellular glutathione, GGT activity should be antioxidative. Alternatively, serum GGT activity may reflect amounts of glutathione conjugates formed during the metabolism of xenobiotics. Accordingly, we postulate a two-part hypothesis: that the association of serum GGT with type 2 diabetes reflects exposure to POPs, as these substances, which have a very long half-life, may influence diabetes risk by residing in adipose tissue as endocrine disruptors; and that POPs or similar substances may interact with obesity to cause type 2 diabetes. Supporting this hypothesis, cross-sectional investigation of background exposure to POPs in the National Health and Nutrition Examination Survey showed relationships similar to those observed for GGT, including a powerful association with prevalent diabetes and no association between obesity and diabetes for very low POP concentrations. Our hypothesis can be tested in both prospective studies and toxicological studies.
引用
收藏
页码:402 / 407
页数:6
相关论文
共 50 条
  • [42] PEBBLE WE, 1923, BOSTON MED SURG J, V188, P617
  • [43] γ-glutamyltransferase as a risk factor for cardiovascular disease mortality -: An epidemiological investigation in a cohort of 163,944 Austrian adults
    Ruttmann, E
    Brant, LJ
    Concin, H
    Diem, G
    Rapp, K
    Ulmer, H
    [J]. CIRCULATION, 2005, 112 (14) : 2130 - 2137
  • [44] γ-Glutamltransferase rase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men
    Ryu, Seungho
    Chang, Yoosoo
    Kim, Dong-Il
    Kim, Won Sool
    Suh, Byung-Seong
    [J]. CLINICAL CHEMISTRY, 2007, 53 (01) : 71 - 77
  • [45] Schrenk D, 1998, BIOCHEM PHARMACOL, V55, P1155
  • [46] GLUTATHIONE METABOLISM BY GAMMA-GLUTAMYL-TRANSPEPTIDASE LEADS TO LIPID-PEROXIDATION - CHARACTERIZATION OF THE SYSTEM AND RELEVANCE TO HEPATOCARCINOGENESIS
    STARK, AA
    ZEIGER, E
    PAGANO, DA
    [J]. CARCINOGENESIS, 1993, 14 (02) : 183 - 189
  • [47] Glutathione-S-transferase family of enzymes
    Strange, RC
    Spiteri, MA
    Ramachandran, S
    Fryer, AA
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2001, 482 (1-2) : 21 - 26
  • [48] Oxidative damage in chemical teratogenesis
    Wells, PG
    Kim, PM
    Laposa, RR
    Nicol, CJ
    Parman, T
    Winn, LM
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1997, 396 (1-2) : 65 - 78
  • [49] Gamma glutamyl transferase
    Whitfield, JB
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2001, 38 (04) : 263 - 355
  • [50] Whitfield JB, 2007, CLIN CHEM, V53, P1, DOI 10.1373/clinchem.2006.080432